|
Gland Pharma Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
27637.89 Cr.
|
P/BV
|
2.81
|
Book Value (Rs.)
|
596.28
|
|
52 Week High/Low (Rs.)
|
2131/1278
|
FV/ML
|
1/1
|
P/E(X)
|
39.57
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
42.40
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 5583.63 | 5641.73 | 3591.86 | 4384.15 | 3423.64 |
| Other Operating Revenues | 32.88 | 22.99 | 32.74 | 16.56 | 39.24 |
| Total Operating Revenues | 5616.50 | 5664.72 | 3624.60 | 4400.71 | 3462.88 |
| | | | | | |
| Other Income | 213.61 | 170.24 | 240.46 | 223.94 | 134.78 |
| Total Revenue | 5830.11 | 5834.96 | 3865.06 | 4624.65 | 3597.65 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 2171.63 | 2252.13 | 1716.75 | 2046.86 | 1749.16 |
| Purchase Of Stock-In Trade | 14.49 | 23.07 | 15.59 | 25.67 | 16.20 |
| Operating And Direct Expenses | 0.00 | 0.00 | 124.84 | 95.05 | 74.59 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 103.41 | 127.89 | -46.92 | 36.69 | -273.49 |
| Employee Benefit Expenses | 1401.56 | 1256.89 | 403.26 | 338.57 | 311.36 |
| Finance Costs | 42.00 | 26.20 | 7.45 | 5.24 | 3.41 |
| Depreciation And Amortisation Expenses | 377.87 | 344.57 | 146.74 | 110.30 | 98.78 |
| Other Expenses | 656.48 | 671.68 | 386.31 | 347.72 | 282.83 |
| Total Expenses | 4767.45 | 4702.42 | 2754.02 | 3006.09 | 2262.84 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 1062.66 | 1132.54 | 1111.04 | 1618.55 | 1334.81 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | -56.46 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 1062.66 | 1132.54 | 1054.58 | 1618.55 | 1334.81 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 370.98 | 349.30 | 277.16 | 395.88 | 339.45 |
| Deferred Tax | -7.84 | 14.33 | -2.80 | 14.01 | 0.12 |
| Tax For Earlier Years | 0.99 | -3.55 | -0.82 | -3.00 | -1.72 |
| Total Tax Expenses | 364.13 | 360.08 | 273.54 | 406.89 | 337.85 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 698.53 | 772.46 | 781.04 | 1211.66 | 996.96 |
| | | | | | |
| Profit/Loss From Continuing Operations | 698.53 | 772.46 | 781.04 | 1211.66 | 996.96 |
| | | | | | |
| Profit/Loss For The Period | 698.53 | 772.46 | 781.04 | 1211.66 | 996.96 |
| Consolidated Profit/Loss After MI And Associates | 698.53 | 772.46 | 781.04 | 1211.66 | 996.96 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 42.40 | 46.90 | 47.44 | 73.81 | 63.07 |
| Diluted EPS (Rs.) | 42.40 | 46.90 | 47.43 | 73.81 | 62.99 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 329.50 | 0.00 | 0.00 | 0.00 | 0.00 |
